Skip to main content

Mucus Relief DM

NDC 67091-344 · WinCo Foods, LLC

Generic nameGuaifenesin, Dextromethorphan HBr
Dosage formTABLET
RouteORAL
Active ingredient(s)GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE
Strength30; 600 mg/1; mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

67091-344-20 — 20 BLISTER PACK in 1 CARTON (67091-344-20) / 1 TABLET in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

67091-265 — Dextromethorphan HBr, Guaifenesin, 67091-266 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 67091-287 — Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, 67091-288 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 67091-299 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 67091-314 — Guaifenesin and Dextromethorphan HBr, 67091-315 — Guaifenesin and Dextromethorphan HBr, 67091-322 — ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE, 67091-338 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, 67091-342 — Dextromethorphan HBr and Guaifenesin, 67091-345 — Guaifenesin, Dextromethorphan HBr, 67091-349 — ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, 67091-355 — Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride, 67091-370 — Guaifenesin, 67091-394 — Acetaminophen, Dextromethorphan HBr, Phenylephrine HCL, 67091-395 — ACETAMINOPHEN DEXTROMETHORPHAN HYDROBROMIDE DOXYLAMINE SUCCINATE, 67091-403 — Guaifenesin, 67091-404 — Guaifenesin, 67091-457 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 67091-469 — Dextromethorphan HBr, Guaifenesin, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels